Sitravatinib T4349
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFR_/_, PDGFR, and Axl.
CAS nr:
1123837-84-2
Purity:
98%
Molecular Weight:
629,68
SMILES:
COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
Formula:
C33H29F2N5O4S
Pathway:
Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors
Target:
Discoidin Domain Receptor (DDR),VEGFR,VEGFR,TAM Receptor,Trk receptor,Ephrin Receptor,c-Kit,FLT,FLT
